giovedì 28 maggio 2020

FDA Approves First Treatment for a Form of Bladder Dysfunction in Pediatric Patients as Young as 2 Years of Age - VESIcare LS (solifenacin succinate)

Fonte:
FDA Food and Drug Administration

Link all'articolo completo